EKOS™ Endovascular System
Real world. Real answers. REAL-PE.
The EKOS™ Endovascular System is the most studied device in the pulmonary embolism space. Since 2014, several major studies have demonstrated clinically significant results in quality of life scores1, mortality2, and long-term safety and efficacy1,3,4 for acute, massive (high risk) and submassive (intermediate risk) PE.
- EKOS brings 23-26% reduction to the RV/LV ratio – without an increase in bleeding1, 3,4
- It allows for lower lytic doses – up to 88-92% less than for standard systemic treatment – and shorter delivery duration of the thrombolytic agent5,1
- It enables shorter average length of hospital stay (3.2 days)than for patients being treated with anticoagulation alone (6.7 days)6
Access full clinical overview of EKOS ultrasound-assisted thrombolysis for Pulmonary Embolism.
Deep Vein Thrombosis
The EKOSTM Endovascular System quickly restores blood flow, potentially reducing the risk of pulmonary embolism and post-thrombotic syndrome (PTS).
- Up to 50% of DVT patients have PE7
- Removes thrombus more completely compared to CDT8
- Reduces post-thrombotic syndrome9
Completed studies on EKOS™ for DVT are:
CAVA: A randomised controlled multicenter trial comparing ultrasound-accelerated catheter-directed thrombolysis, combined with standard anticoagulant therapy, with standard anticoagulant therapy alone, for acute primary iliofemoral deep vein thrombosis (Level 1) A.
ACCESS PTS: ACCElerated ThrombolySiS for Post-Thrombotic Syndrome Using the EKOS™ System (Level 2) Chronicdvtstudy.com
The EKOSTM Endovascular System improves on standard CDT by safely accelerating drug penetration, even in difficult-to-reach areas:
- Shorter treatment times11
- Lower 30-day amputation rate11
- Lower bleeding rates when compared to CDT11
- Higher complete dissolution rate of thrombus11
- Shorter hospital stays11
Completed trials on EKOSTM for PAO are:
DUET: Dutch randomised trial comparing standard catheter-directed thrombolysis versus ultrasound-accelerated thrombolysis for thrombo-embolic infra-inguinal.